Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.
NCI Provides $40 Million To Four Centers For Cancer Communications Research.
Talpin To Join NCI
Pat Barr, Early NBCC Activist, Dead.
Cancer Groups Criticize Prescription Drug Bills.
AstraZeneca To Pay $335M In Illegal Pricing Penalties.
GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.
Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater